Estíbaliz Miranda

876 total citations
17 papers, 232 citations indexed

About

Estíbaliz Miranda is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Estíbaliz Miranda has authored 17 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Hematology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Estíbaliz Miranda's work include Epigenetics and DNA Methylation (5 papers), Histone Deacetylase Inhibitors Research (5 papers) and Acute Myeloid Leukemia Research (4 papers). Estíbaliz Miranda is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Histone Deacetylase Inhibitors Research (5 papers) and Acute Myeloid Leukemia Research (4 papers). Estíbaliz Miranda collaborates with scholars based in Spain, China and Germany. Estíbaliz Miranda's co-authors include Xabier Agirre, Felipe Prósper, Leire Gárate, Edurne San José‐Eneriz, Amaia Vilas‐Zornoza, José I. Martı́n-Subero, J. Rifón, Iñigo Apaolaza, Marı́a José Calasanz and Francisco J. Planes and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Estíbaliz Miranda

16 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Estíbaliz Miranda Spain 8 191 50 43 31 23 17 232
Blerim Marovca Switzerland 6 113 0.6× 31 0.6× 36 0.8× 49 1.6× 8 0.3× 9 172
Laura Hinze Germany 5 119 0.6× 15 0.3× 69 1.6× 40 1.3× 30 1.3× 12 222
Guillermo Garcia-Manero United States 5 90 0.5× 97 1.9× 93 2.2× 44 1.4× 27 1.2× 14 216
Hayato Tamai Japan 6 78 0.4× 60 1.2× 36 0.8× 28 0.9× 8 0.3× 19 145
Bruno A. Lopes Brazil 7 71 0.4× 54 1.1× 45 1.0× 18 0.6× 25 1.1× 20 126
Valeria Cazzaniga Italy 4 61 0.3× 29 0.6× 39 0.9× 22 0.7× 20 0.9× 7 129
Emanuela Ferrari Italy 9 228 1.2× 51 1.0× 25 0.6× 57 1.8× 3 0.1× 13 298
Bonnie Le United States 3 124 0.6× 40 0.8× 12 0.3× 35 1.1× 4 0.2× 4 157
Clarissa Kooi Netherlands 6 100 0.5× 105 2.1× 132 3.1× 42 1.4× 25 1.1× 7 254
Wai Kin Chan United States 7 194 1.0× 10 0.2× 141 3.3× 30 1.0× 48 2.1× 11 297

Countries citing papers authored by Estíbaliz Miranda

Since Specialization
Citations

This map shows the geographic impact of Estíbaliz Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estíbaliz Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estíbaliz Miranda more than expected).

Fields of papers citing papers by Estíbaliz Miranda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Estíbaliz Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estíbaliz Miranda. The network helps show where Estíbaliz Miranda may publish in the future.

Co-authorship network of co-authors of Estíbaliz Miranda

This figure shows the co-authorship network connecting the top 25 collaborators of Estíbaliz Miranda. A scholar is included among the top collaborators of Estíbaliz Miranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Estíbaliz Miranda. Estíbaliz Miranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Blanco, Rafael, Gloria Abizanda, Estíbaliz Miranda, et al.. (2024). HDACi vorinostat protects muscle from degeneration after acute rotator cuff injury in mice. Bone and Joint Research. 13(4). 169–183.
2.
José‐Eneriz, Edurne San, Leire Gárate, Estíbaliz Miranda, et al.. (2022). Identifying Lethal Dependencies with HUGE Predictive Power. Cancers. 14(13). 3251–3251. 7 indexed citations
3.
Rabal, Obdulia, Edurne San José‐Eneriz, Xabier Agirre, et al.. (2021). Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma. Journal of Medicinal Chemistry. 64(6). 3392–3426. 22 indexed citations
4.
Martínez‐Calle, Nicolás, Marién Pascual, Raquel Ordóñez, et al.. (2019). Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated. Haematologica. 104(8). 1572–1579. 18 indexed citations
5.
Rabal, Obdulia, Estíbaliz Miranda, Leire Gárate, et al.. (2019). Differentiation Therapy with Novel Epigenetic Inhibitors in Acute Myeloid Leukemia. Blood. 134(Supplement_1). 3762–3762. 1 indexed citations
6.
Rabal, Obdulia, Juan A. Sánchez‐Arias, Edurne San José‐Eneriz, et al.. (2018). Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces. Journal of Medicinal Chemistry. 61(15). 6546–6573. 23 indexed citations
7.
Rodríguez-Madoz, Juan R., Edurne San José‐Eneriz, Obdulia Rabal, et al.. (2017). Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome. PLoS ONE. 12(12). e0190275–e0190275. 11 indexed citations
8.
Pey, Jon, Edurne San José‐Eneriz, María C. Ochoa, et al.. (2017). In-silico gene essentiality analysis of polyamine biosynthesis reveals APRT as a potential target in cancer. Scientific Reports. 7(1). 14358–14358. 16 indexed citations
9.
Apaolaza, Iñigo, Edurne San José‐Eneriz, Luis Tobalina, et al.. (2017). An in-silico approach to predict and exploit synthetic lethality in cancer metabolism. Nature Communications. 8(1). 459–459. 38 indexed citations
10.
José‐Eneriz, Edurne San, Xabier Agirre, Obdulia Rabal, et al.. (2014). Inhibition of the Methyltransferase G9a with Small Molecules As a New Therapeutic Strategy for Treatment of Hematological Malignancies. Blood. 124(21). 3532–3532. 2 indexed citations
11.
Vilas‐Zornoza, Amaia, Xabier Agirre, Gloria Abizanda, et al.. (2012). Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia. Leukemia. 26(7). 1517–1526. 38 indexed citations
12.
Agirre, Xabier, Amaia Vilas‐Zornoza, Gloria Abizanda, et al.. (2011). Preclinical Activity of LBH589 Alone or in Combination with Chemotherapy in a Xenogeneic Mouse Model of Human Acute Lymphoblastic Leukemia. Blood. 118(21). 1520–1520. 3 indexed citations
13.
Vilas‐Zornoza, Amaia, Xabier Agirre, José I. Martı́n-Subero, et al.. (2011). Frequent and Simultaneous Epigenetic Inactivation of TP53 Pathway Genes in Acute Lymphoblastic Leukemia. PLoS ONE. 6(2). e17012–e17012. 42 indexed citations
14.
Miranda, Estíbaliz, et al.. (2001). Alteraciones cromosómicas en la leucemia linfoblástica aguda. Anales de Pediatría. 55(1). 45–52. 2 indexed citations
15.
Rodríguez, Maria José, et al.. (2000). Genética de las cardiopatías congénitas. Anales de Pediatría. 53(1). 30–39. 2 indexed citations
16.
Miranda, Estíbaliz, et al.. (1999). [Fanconi's anemia].. PubMed. 44(1). 55–64. 6 indexed citations
17.
Pozo, Jaime Sánchez del, et al.. (1998). [WAGR syndrome: a case report].. PubMed. 49(4). 381–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Blerim Marovca Breakdown of academic impact, for papers by Laura Hinze Breakdown of academic impact, for papers by Guillermo Garcia-Manero Breakdown of academic impact, for papers by Hayato Tamai Breakdown of academic impact, for papers by Bruno A. Lopes Breakdown of academic impact, for papers by Valeria Cazzaniga Breakdown of academic impact, for papers by Emanuela Ferrari Breakdown of academic impact, for papers by Bonnie Le Breakdown of academic impact, for papers by Clarissa Kooi Breakdown of academic impact, for papers by Wai Kin Chan
Rankless by CCL
2026